Literature DB >> 26306456

Differences in ventricular tachyarrythmias and antitachycardia pacing effectiveness according to the ICD indication (primary versus secondary prevention): an analysis based on the stored electrograms.

Javier Jiménez-Candil1, Jesús Hernández2, Ana Martín2, José Moríñigo2, Pedro Perdiguero2, Loreto Bravo2, Sonia Ruiz2, Pedro L Sánchez2.   

Abstract

PURPOSE: To determine whether monomorphic ventricular tachycardias (VTs) have different characteristics and/or responses to antitachycardia pacing (ATP) with respect to the indication-primary prevention (PP) versus secondary prevention (SP)-among ICD patients with left ventricular dysfunction.
METHODS: We prospectively studied 551 VT (cycle length [CL] 329 ± 35 ms; PP 34%) occurring in 67 ICD patients with left ventricular dysfunction (LVEF 35 ± 8%). ICD programming was standardized, including ATP for slow (CL 400-321 ms) and fast VT (CL 250-320 ms). We analyzed the following aspects: CL, percentage of variability of the 12 RR intervals prior to ATP (P-RR)-which was calculated by dividing the mean difference between each R-R interval with the next one by the CL × 100-and type of termination: immediate (VT ceased immediately upon ATP completion) or delayed (VT persisted after ATP).
RESULTS: ATP was successful in 86% of VTs. VTs occurring in SP patients had a lower P-RR, median (IQR) 2.7% (1.2-3.7) versus 1.9% (0.9-3.2); p = 0.002; they terminated immediately after ATP less frequently (27% versus 12%; p < 0.001), and although they were more frequently slow (51% versus 67%; p = 0.01), ATP was less effective in them, 92 versus 80% (p = 0.02).
CONCLUSIONS: VTs occurring in SP patients are slower, more stable, and they terminate less frequently at ATP. Therefore, compared with PP, SP patients seem to have fewer self-terminating VTs.

Entities:  

Keywords:  Antitachycardia pacing; Implantable cardiac defibrillator; Shock; Ventricular tachycardia

Mesh:

Year:  2015        PMID: 26306456     DOI: 10.1007/s10840-015-0050-0

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  20 in total

Review 1.  Antitachycardia pacing for ventricular tachycardia using implantable cardioverter defibrillators:.

Authors:  Michael O Sweeney
Journal:  Pacing Clin Electrophysiol       Date:  2004-09       Impact factor: 1.976

2.  EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias: developed in a partnership with the European Heart Rhythm Association (EHRA), a Registered Branch of the European Society of Cardiology (ESC), and the Heart Rhythm Society (HRS); in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA).

Authors:  Etienne M Aliot; William G Stevenson; Jesus Ma Almendral-Garrote; Frank Bogun; C Hugh Calkins; Etienne Delacretaz; Paolo Della Bella; Gerhard Hindricks; Pierre Jaïs; Mark E Josephson; Josef Kautzner; G Neal Kay; Karl-Heinz Kuck; Bruce B Lerman; Francis Marchlinski; Vivek Reddy; Martin-Jan Schalij; Richard Schilling; Kyoko Soejima; David Wilber
Journal:  Europace       Date:  2009-05-14       Impact factor: 5.214

3.  Morphology of far-field electrograms and antitachycardia pacing effectiveness among fast ventricular tachycardias occurring in ICD patients: a multicenter study.

Authors:  Javier Jiménez-Candil; Ignasi Anguera; Claudio Ledesma; Javier Fernández-Portales; José Luis Moríñigo; Paolo Dallaglio; Ana Martín; Teresa Cano; Jesús Hernández; Xavier Sabaté; Cándido Martín-Luengo
Journal:  J Cardiovasc Electrophysiol       Date:  2013-09-09

4.  Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.

Authors:  Arthur J Moss; Wojciech Zareba; W Jackson Hall; Helmut Klein; David J Wilber; David S Cannom; James P Daubert; Steven L Higgins; Mary W Brown; Mark L Andrews
Journal:  N Engl J Med       Date:  2002-03-19       Impact factor: 91.245

5.  Influence of beta-blocker therapy on antitachycardia pacing effectiveness for monomorphic ventricular tachycardias occurring in implantable cardioverter-defibrillator patients: a dose-dependent effect.

Authors:  Javier Jiménez-Candil; Jesús Hernández; Ana Martín; María Ruiz-Olgado; Jesús Herrero; Claudio Ledesma; José Moríñigo; Cándido Martín-Luengo
Journal:  Europace       Date:  2010-06-04       Impact factor: 5.214

6.  Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact.

Authors:  James P Daubert; Wojciech Zareba; David S Cannom; Scott McNitt; Spencer Z Rosero; Paul Wang; Claudio Schuger; Jonathan S Steinberg; Steven L Higgins; David J Wilber; Helmut Klein; Mark L Andrews; W Jackson Hall; Arthur J Moss
Journal:  J Am Coll Cardiol       Date:  2008-04-08       Impact factor: 24.094

7.  Discrimination of ventricular tachycardia from sinus tachycardia and atrial fibrillation in a tiered-therapy cardioverter-defibrillator.

Authors:  C D Swerdlow; P S Chen; R M Kass; J R Allard; C T Peter
Journal:  J Am Coll Cardiol       Date:  1994-05       Impact factor: 24.094

8.  Incidence and characteristics of type-2 breaks in response to antitachycardia pacing therapy in implantable cardioverter defibrillator patients.

Authors:  Vinod Sharma; Paul J DeGroot; Mark S Wathen
Journal:  J Cardiovasc Electrophysiol       Date:  2003-11

9.  Characterization of oscillations in ventricular refractoriness in man after an abrupt increment in heart rate.

Authors:  F E Marchlinski
Journal:  Circulation       Date:  1987-03       Impact factor: 29.690

10.  Influence of cycle length variations on antitachycardia pacing effectiveness among ICD patients.

Authors:  Javier Jiménez-Candil; Jesús Hernández; Ana Martín; José Moríñigo; Rosana López; Claudio Ledesma; Cándido Martín-Luengo
Journal:  Heart Rhythm       Date:  2012-10-18       Impact factor: 6.343

View more
  2 in total

1.  Effectiveness of first versus successive antitachycardia pacing attempts: predictors and clinical consequences.

Authors:  Javier Jiménez-Candil; Olga Durán; Jean Núñez; Loreto Bravo; Jesús Hernández; Ana Martín-García; José Morínigo; Pedro L Sánchez
Journal:  J Interv Card Electrophysiol       Date:  2019-09-16       Impact factor: 1.900

2.  An inappropriate pacing threshold increase after repeated electrical storm in a patient with implantable cardioverter defibrillator.

Authors:  Ye Zhu; Xiang Gu; Chao Xu
Journal:  BMC Cardiovasc Disord       Date:  2017-10-16       Impact factor: 2.298

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.